Abbott's Emerging Markets Strategy Gets A Bump With Piramal Buy
NEW DELHI - Abbott is set to become India's largest pharmaceutical company after it announced a $3.72 billion deal to acquire the domestic formulations business of Mumbai-based Piramal Healthcare May 21